Drugs, Drug Proprietors & Druggists' Sundries.
Wholesale pharmaceutical and druggist supplies.
- MCC
- 5122
- Category
- Retail Outlets
- Cardflo support
- Yes
What MCC 5122 covers
Merchant Category Code 5122 is the ISO 18245 identifier used by the card networks for drugs, drug proprietors & druggists' sundries. Acquirers, issuers and regulators use this code to set interchange, scheme fees, fraud rules and reporting categories for every transaction your business processes.
Wholesale pharmaceutical and druggist supplies. Choosing the right MCC is critical: an incorrect code can lead to higher interchange, surcharges, or, in regulated categories, declined transactions and account holds.
This MCC covers wholesale distributors of pharmaceutical products, drugs, and related druggists' sundries. Merchants typically supply pharmacies, hospitals, and clinics.
Due to the regulated nature of the products, ticket sizes can be substantial and orders are generally frequent and ongoing. Transaction frequency is driven by regular stock replenishment needs of healthcare providers.
Chargebacks are relatively low outside of specific product issues, with common reasons being 'merchandise not as described' (e. g. , incorrect drug potency or formulation), 'goods not received' (e. g. , temperature-sensitive delivery failures), or 'counterfeit merchandise' disputes for unapproved or fraudulent products.
Due to the sensitive nature of pharmaceuticals, explicit regulatory compliance is paramount, impacting scheme monitoring.
Cardflo's KYB process is designed to thoroughly vet these merchants for appropriate licensing and compliance, enhancing trust and reducing scheme risk, supported by our robust chargeback analytics to identify underlying issues.
Wholesale pharmaceutical distributors must ensure their payment acceptance integrates stringent regulatory compliance checks. Due to varying ticket sizes and product sensitivities, consider multi-acquirer routing to optimise for approval rates and costs.
For highly regulated or high-value narcotics, ensure delivery methods are trackable and require signature on receipt, integrating this data into your transaction records. Clearly define and communicate your returns and quality control policies to institutional clients, as product integrity is paramount.
Tokenisation for repeat institutional orders can streamline reordering whilst maintaining security.
Acquirer and acquirer assessment stance.
Regulated. Due to the highly regulated nature of pharmaceuticals, strict adherence to licensing and industry-specific regulations is required.
Standard reserves may be applied based on the merchant's financial stability and specific product lines.
Dispute and chargeback profile.
The primary chargebacks in this sector are 13.1 / 4853 (services not as described) for product specification variances, 13.1 / 4855 (merchandise not received) for delivery issues, and potentially 13.1 / 4853 (counterfeit merchandise).
Goods not as described may stem from formulation discrepancies; detailed batch records and quality control certificates are vital evidence. For delivery failures, secure, temperature-controlled logistics tracking and signed proof of delivery are essential.
Counterfeit claims require proof of authorised sourcing and authenticity certificates.
See also: chargeback management · payment response codes · Compelling Evidence 3.0.
Book a scoping call to see how Cardflo would set you up.
How Cardflo handles MCC 5122
- Placement with acquirers that actively board MCC 5122 businesses in your region.
- High-volume, low-ticket processing tuned for retail authorisation patterns.
- Omnichannel routing across in-store, e-commerce and click-and-collect.
- EMV, contactless and wallet acceptance enabled on a single integration.
- Refund, void and partial-capture flows aligned with retail operations.
- Dedicated onboarding manager experienced with multi-location retail brands.
Payment methods typically enabled.
Onboarding checklist.
What acquirers typically ask to see when boarding MCC 5122. Cardflo collects this once and reuses it across every acquirer we route you through.
- Business registration and beneficial-owner documentation (KYB, UBO).
- Six months of processing statements or bank statements demonstrating in-store and e-commerce split.
- Refund, exchange and returns policy visible at point of sale and on the website.
- PCI DSS SAQ appropriate to the environment (A, A-EP or D as relevant).
- Store-front address list for multi-location operators.
- Regulator authorisation reference and any statutory notice, licence or product-certification documents that apply to the category.
See also: Know Your Customer (KYC) · high-risk merchant · smart routing.
Talk to an acquiring specialist about your MID setup.
Common questions
What specific licences or certifications are required for a merchant in MCC 5122 to process payments?
Merchants in MCC 5122 must typically hold wholesale distribution authorisations or licences from relevant national health authorities (e. g. , MHRA in the UK, FDA in the US). These licences assure the legitimacy of their pharmaceutical supply chain.
Cardflo's KYB process requires submission and verification of these documents as part of the onboarding.
How does product recall affect chargebacks for wholesale pharmaceutical distributors?
In the event of a product recall, substantial chargebacks for 'merchandise not as described' or 'goods not received' can occur, as clients may reject or return recalled stock. Proactive communication and efficient return processes, alongside robust record-keeping, are essential to disputing these effectively.
Cardflo's chargeback tooling can help categorise and provide evidence for such cases.
Are there particular scheme rules regarding temperature-controlled shipments for pharmaceuticals?
While no specific MCC 5122 scheme rule dictates temperature control, 'goods not received' or 'merchandise not as described' chargebacks can arise if products are compromised during shipping due to improper temperature. Merchants should maintain clear delivery records, including temperature logs, to assist in chargeback representment.
Visa's Integrity Risk Program may flag merchants with frequent issues related to product integrity.
How can we satisfy regulatory requirements whilst processing payments for controlled pharmaceutical products?
To satisfy regulatory requirements, ensure your payment gateway and acquiring setup can associate transaction data with specific product SKUs, batch numbers, and regulatory approvals. Implement robust KYC and KYB processes for all institutional clients.
For payments involving controlled substances, integrate verification steps during the order and dispatch process. Your acquirer partners must be aware of and comfortable with the regulatory aspects of your business, ensuring their risk parameters align.
Maintain impeccable records of all licenses, permits, and product authenticity certificates, ready for audit or dispute defence.
What specific payment security measures should we implement for high-value or temperature-sensitive pharmaceutical shipments?
For high-value or temperature-sensitive shipments, payment security extends beyond card data. Ensure your delivery tracking integrates with your order management system, providing real-time updates and proof of successful, compliant delivery, including temperature logs if applicable.
For card payments, strong customer authentication (SCA) via 3DS2 should be consistently applied. Consider offering secure invoicing options for larger B2B transactions that utilise bank transfers, reducing card scheme fraud exposure and offering irreversible payment finality.
Tokenise customer card details only after meeting PCI DSS standards to streamline repeat orders securely.
Other MCCs in Retail Outlets
Related industries.
Related guides.
Ready to improve your payments setup?
Tell us about your business. We'll match you with the right acquiring partners and the right route, typically inside a week.